合成协议,结构性活动关系和皮佩拉津及其衍生物的生物活性
Md Faizan1, Rajnish Kumar1, Avijit Mazumder1
1Department of Pharmaceutical Chemistry, Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida-201310, India.
Medicinal chemistry (Shariqah (United Arab Emirates))
|April 30, 2024
概括
皮佩拉衍生物是药物发现的多功能支架,提供诸如生物可用性等有利的特性. 本综述强调了新生物活性分子的最新合成方法和结构-活性关系.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 皮佩拉津的基本结构使得它能够制造出用于各种疾病的新生物活性分子.
- 皮佩拉衍生物具有独特的,可修改的结构,用于所需的药理活性.
- 皮佩拉津环中的原子提供极性,刚性和结合能力,增强药物特性.
研究的目的:
- 审查最近发表的皮佩拉津及其衍生物的合成协议.
- 突出皮佩拉含有药物的结构-活性关系,用于各种生物活动.
- 为了帮助研究人员在未来对基于皮佩拉的化合物的研究.
主要方法:
- 对最近的合成协议的文献综述 piperazine衍生物.
- 从已发表的研究中分析结构-活动关系.
- 收集有关药理活动和药物特性数据.
主要成果:
- 详细介绍了最近在合成方法上对皮佩拉衍生物的进展.
- 确定了影响生物活动的关键结构-活动关系.
- 强调了皮佩拉津化合物的有利ADME特性和标特异性.
结论:
- 皮佩拉衍生物是开发新疗法的有希望的支架.
- 了解合成路径和结构-活性关系对于药物设计至关重要.
- 这篇评论为研究人员在基于piperazine的药物发现中提供了宝贵的资源.
相关概念视频
Structure-Activity Relationships and Drug Design
708
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
708
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.0K
Basicity of Heterocyclic Aromatic Amines
6.0K
Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
6.0K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
950
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
950
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.2K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
555
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
555


